New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Regulus Therapeutics Inc.
RGLS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

84M

Biotechnology

Next Earning date - 20 Mar 2025

84M

Biotechnology

Next Earning date - 20 Mar 2025

1.28USD
Shape0.01 ( 0.79%)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

34%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

66%

Quote Panel

Shape
Updated January 17, 2025
1W -1.54 % 1M -15.23 % 3M -18.47 % 1Y 4.92 %

Key Metrics

Shape
  • Market Cap

    83.84M


  • Shares Outstanding

    65.50M


  • Share in Float

    52.41M


  • Dividende

    0


  • Earning Date

    20 Mar 2025


  • Price Target

    1.28


  • Average Volume

    355111


  • Beta

    1.628


  • Range

    1.13-3.79


  • Industry

    Biotechnology


  • Website

    https://www.regulusrx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

RGLS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.24

Shape-490%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Oppenheimer

initialise

Previous: Not converted

2024-08-01

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.40
vs -0.70

Q1.23

arrow
arrow

N/A

-0.42
vs -0.50

Q2.23

arrow
arrow

N/A

-0.37
vs -0.50

Q3.23

arrow
arrow

N/A

-0.40
vs -0.50

Q4.23

arrow
arrow

N/A

-0.40
vs -0.40

Q1.24

arrow
arrow

N/A

-0.29
vs -0.42

Q2.24

arrow
arrow

N/A

-0.17
vs -0.37

Q3.24

arrow
arrow

N/A

-0.21
vs -0.40

Q4.24

arrow
arrow

N/A

-0.21
vs -0.40

Q1.25

arrow
arrow

N/A

-0.23
vs -0.29

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

302K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-20%

-0.20
vs -0.19

Q1.23

arrow
arrow

-27%

-0.27
vs -0.20

Q2.23

arrow
arrow

-21%

-0.21
vs -0.27

Q3.23

arrow
arrow

-28%

-0.28
vs -0.21

Q4.23

arrow
arrow

-38%

-0.38
vs -0.28

Q1.24

arrow
arrow

-8%

-0.08
vs -0.38

Q2.24

arrow
arrow

-11%

-0.11
vs -0.08

Q3.24

arrow
arrow

-16%

-0.16
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

24

24
vs 20

20%

Q1.23

arrow
arrow

23

23
vs 24

-4%

Q2.23

arrow
arrow

23

23
vs 23

NA

Q3.23

arrow
arrow

24

24
vs 23

4%

Q4.23

arrow
arrow

25

25
vs 24

4%

Q1.24

arrow
arrow

47

47
vs 25

88%

Q2.24

arrow
arrow

65

65
vs 47

38%

Q3.24

arrow
arrow

74

74
vs 65

14%

Earnings Growth

Latest News